Lisanti Capital Growth, LLC Corcept Therapeutics Inc Transaction History
Lisanti Capital Growth, LLC
- $344 Million
- Q3 2024
A detailed history of Lisanti Capital Growth, LLC transactions in Corcept Therapeutics Inc stock. As of the latest transaction made, Lisanti Capital Growth, LLC holds 113,155 shares of CORT stock, worth $5.75 Million. This represents 1.52% of its overall portfolio holdings.
Number of Shares
113,155
Previous 62,995
79.63%
Holding current value
$5.75 Million
Previous $2.05 Million
155.82%
% of portfolio
1.52%
Previous 0.53%
Shares
2 transactions
Others Institutions Holding CORT
# of Institutions
346Shares Held
86.1MCall Options Held
1.12MPut Options Held
667K-
Black Rock Inc. New York, NY16.5MShares$841 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$509 Million0.01% of portfolio
-
Ingalls & Snyder LLC New York, NY8.27MShares$420 Million14.93% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny6.51MShares$331 Million0.48% of portfolio
-
Parallel Advisors, LLC3.81MShares$194 Million4.22% of portfolio
About CORCEPT THERAPEUTICS INC
- Ticker CORT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,105,000
- Market Cap $5.45B
- Description
- Corcept Therapeutics Incorporated discovers, develops, and commercializes drugs for the treatment of severe metabolic, oncologic, and neuropsychiatric disorders in the United States. The company offers Korlym (mifepristone) tablets as a once-daily oral medication for the treatment of hyperglycemia secondary to hypercortisolism in adult patients ...